glp 1 makes me cold GLP-1 Gave Energy Boosts and Shakes - Here's Why 3 science-backed reasons you may

The comparability of patient characteristics between two study groups was achieved by the three-step matching on (1) the index date, (2) prior exposure to GLAs in the year before the index date, and (3) patient demographic and clinical characteristics (e.g., diabetes severity, comorbidities, co-medications for cardiovascular diseases [CVDs]) using the propensity score matching approach [6]

5 The annual incidence ranges from 8.8 to 23.1 per 100,000 person-years in North America, 0.624.3 per 100,000 person-years in Europe, and 7.317.4 per 100,000 person-years in Oceania, with a prevalence in adults in their 30 s and 40 s

Food and Drug Administration approved its daily oral orforglipron pill, which will be marketed under the name Foundayo, to treat obesity

While it has gained credibility, its not without criticism

PMID: 25791371

Walk it out